Skip to main content

Table 2 OCT features of eyes with steroid induced CSC (group A) and those with idiopathic CSC (group B)

From: Retinal and choroidal changes in steroid-associated central serous chorioretinopathy

  Group A N = 20 eyes Group B N = 30 eyes P value OR (95% CI) P value
CMT (µm ± SD) 370.25 ± 156.39 484.63 ± 222.02 0.08
NSD height (µm ± SD) 153.1 ± 175.70 312.9 ± 223.06 < 0.01*
Subretinal deposits 4/20 (20%) 12/30 (40%) 0.22 0.38 (0.10–1.40) 0.14
RPE irregularities 5/20 (25%) 5/30 (16.67%) 0.49 1.67 (0.41–6.73) 0.47
PED 5/20 (25%) 11/30 (36.67%) 0.54 0.58 (0.16–2.02) 0.39
Double layer sign 4/20 (20%) 11/30 (36.67%) 0.35 0.43 (0.11–1.62) 1.24
Outer retinal layer disruption 0/20 (0%, 95% CI, 0–16.11%) 2/30 (6.67%) 0.51 0.28 (0.01–6.10) 0.42
Hyperreflective dots 3/20 (15%) 14/30 (46.67%) 0.03* 0.20 (0.05–0.84) 0.03*
Intraretinal fluid 0/20 (0%, 95% CI, 0–16.11%) 2/30 (6.67%) 0.51 0.28 (0.01–6.10) 0.42
SFCT (µm ± SD) 359.4 ± 49.10 355.53 ± 50.42 0.65
SLCVD (µm ± SD) 162.8 ± 39.01 163.38 ± 49.26 0.78
CVI 82 ± 35% 58 ± 3% 0.10
  1. OCT optical coherence tomography; CMT central macular thickness; NSD neurosensory detachment; RPE retinal pigment epithelium; PED pigment epithelial detachment; CT choroidal thickness; SLCVD subfoveal large choroidal vessel diameter; CVI choroidal vascularity index; OR odds ratio; CI confidence interval
  2. * Statistically significant